TISSUE DISTRIBUTION AND HALF-LIFE OF I-125 ENDOTHELIN IN THE RAT - IMPORTANCE OF PULMONARY CLEARANCE

被引:124
作者
SIRVIO, ML [1 ]
METSARINNE, K [1 ]
SAIJONMAA, O [1 ]
FYHRQUIST, F [1 ]
机构
[1] MINERVA FDN,CLIN PHYSIOL UNIT,TUKHOLMANKATU 2,SF-00250 HELSINKI,FINLAND
关键词
D O I
10.1016/0006-291X(90)90649-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Plasma half-life and organ uptake of endothelin 1 (ET-1) was studied in anaesthetized Wistar rats administering a bolus of 125I-labeled ET-1 into jugular vein, with and without a preceding dose of 1-80 ng of unlabeled ET-1, via the same route. Plasma half-life of intact 125I-ET-1 was 40 sec and that of total radioactivity 68 sec. Immunoreactivity of circulating 125I-ET was rapidly reduced, by 23% at 30 sec and by 43% at 360 sec, respectively. High power liquid chromatography of plasma extracts revealed a corresponding decrease of intact 125I-ET-1 peak with time. There was a predominant uptake of 125I-ET-1 in the lungs, 82%, and lesser by kidneys, 10%, heart 3.6%, liver, 2.7%, and spleen, 1.5%, respectively. Pretreatment with unlabeled ET-1 caused a dose-dependent shift of uptake from lungs to kidneys. We conclude that circulating ET-1 is rapidly cleared, primarily by the lungs, which may play an important role in protecting the systemic circulation from the vasoconstricting actions of ET-1. © 1990.
引用
收藏
页码:1191 / 1195
页数:5
相关论文
共 11 条
[1]  
ANGGARD E, 1989, J CARDIOVASC PHARM, V13, pS46
[2]   IMMUNOREACTIVE ENDOTHELIN IN HUMAN-PLASMA - MARKED ELEVATIONS IN PATIENTS IN CARDIOGENIC-SHOCK [J].
CERNACEK, P ;
STEWART, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :562-567
[3]  
FYHRQUIST F, 1989, 4TH EUR M HYP MIL
[4]   THE HUMAN ENDOTHELIN FAMILY - 3 STRUCTURALLY AND PHARMACOLOGICALLY DISTINCT ISOPEPTIDES PREDICTED BY 3 SEPARATE GENES [J].
INOUE, A ;
YANAGISAWA, M ;
KIMURA, S ;
KASUYA, Y ;
MIYAUCHI, T ;
GOTO, K ;
MASAKI, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2863-2867
[5]   TISSUE SPECIFIC DISTRIBUTION, CLEARANCE AND VASCULAR EFFECTS OF ENDOTHELIN IN THE PIG [J].
PERNOW, J ;
HEMSEN, A ;
LUNDBERG, JM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (02) :647-653
[6]   AUTORADIOGRAPHIC LOCALIZATION OF ENDOTHELIN-1 BINDING-SITES IN THE CARDIOVASCULAR AND RESPIRATORY SYSTEMS [J].
POWER, RF ;
WHARTON, J ;
ZHAO, Y ;
BLOOM, SR ;
POLAK, JM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S50-S56
[7]   ELIMINATION OF INTRAVENOUSLY INJECTED ENDOTHELIN-1 FROM THE CIRCULATION OF THE RAT [J].
SHIBA, R ;
YANAGISAWA, M ;
MIYAUCHI, T ;
ISHII, Y ;
KIMURA, S ;
UCHIYAMA, Y ;
MASAKI, T ;
GOTO, K .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 :S98-S102
[8]   ENDOTOXIN STIMULATES ENDOTHELIN-RELEASE INVIVO AND INVITRO AS DETERMINED BY RADIOIMMUNOASSAY [J].
SUGIURA, M ;
INAGAMI, T ;
KON, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 161 (03) :1220-1227
[9]   DETERMINATION OF IMMUNOREACTIVE ENDOTHELIN IN MEDIUM FROM CULTURED ENDOTHELIAL-CELLS AND HUMAN-PLASMA [J].
XUAN, YT ;
WHORTON, AR ;
SHEARERPOOR, E ;
BOYD, J ;
WATKINS, WD .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 164 (01) :326-332
[10]  
YANAGISAWA M, 1989, TRENDS PHARMACOL SCI, V10, P374